Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × INDUSTRY × Clear all

NCT06077903 2026-05-05

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Adult

NCT06094426 2026-04-29

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT06834542 2026-04-27

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Phase EARLY_PHASE1 Terminated

Adult Gynecological Tumors

NCT07108140 2026-01-22

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT04712721 2025-10-10

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Breast Neoplasms, Glioblastoma

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

Prostatic Neoplasms

NCT04630353 2025-09-12

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Phase EARLY_PHASE1 Terminated

GynecologicHead & Neck

Uterine Cervical Neoplasms, Oropharyngeal Neoplasms

NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumors

NCT03514121 2024-11-22

FPA150-001

Phase EARLY_PHASE1 Terminated

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03893019 2024-05-16

MB-CART20.1 Melanoma

Phase EARLY_PHASE1 Terminated

Melanoma

NCT04116164 2023-09-25

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Phase EARLY_PHASE1 Terminated

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT03224819 2023-09-01

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Phase EARLY_PHASE1 Terminated

46 enrolled 40 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Phase EARLY_PHASE1 Terminated

LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

NCT04102618 2022-08-15

AWARE-1

Phase EARLY_PHASE1 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04272333 2022-04-14

Intratumoral Microdosing of Motolimod in HNSCC

Phase EARLY_PHASE1 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03454243 2019-04-25

TITAN

Phase EARLY_PHASE1 Terminated

DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

NCT01632696 2017-07-11

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT02442466 2015-05-20

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

Phase EARLY_PHASE1 Terminated

Melanoma